Sign In
Buy FENC
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC
09:00pm, Friday, 04'th Mar 2022 NewMediaWire
ROSEN, A LEADING LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Secur
Equities Analysts Offer Predictions for Fennec Pharmaceuticals Inc.’s Q1 2022 Earnings (TSE:FRX)
01:01pm, Thursday, 03'rd Mar 2022 ForexTV
Wedbush decreased their Q1 2022 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a research note issued to investors on Monday, February 28th. Wedbush analyst D. Nierengarten now … Read Full Story at source (may require registration) The post Equities Analysts Offer Predictions for Fennec Pharmaceuticals Inc.’s Q1 2022 Earnings (TSE:FRX) appeared first on ForexTV .
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC
09:32pm, Monday, 28'th Feb 2022 PR Newswire
NEW YORK, Feb. 28, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the "Class Period"), of the important April 11, 2022…
Fennec Pharmaceuticals GAAP EPS of -$0.18 (NASDAQ:FENC)
11:41am, Monday, 28'th Feb 2022 Seeking Alpha
Fennec Pharmaceuticals press release (FENC): Q4 GAAP EPS of -$0.18.Cash and cash equivalent of $21.1M as of December 31, 2021.
ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – FENC
02:10pm, Saturday, 26'th Feb 2022 GlobeNewswire
NEW YORK, Feb. 26, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the “Class Period”) of the important April 11, 2022 lead plaintiff deadline .
The Gross Law Firm Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2022
04:08pm, Friday, 25'th Feb 2022 iCrowdNewswire
The Gross Law Firm issues the following notice on behalf of shareholders of Fennec Pharmaceuticals Inc.. Shareholders who purchased shares of FENC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead […]
FENC SHAREHOLDER ALERT: Jakubowitz Law Reminds Fennec Shareholders of a Lead Plaintiff Deadline of April 11, 2022
11:00am, Friday, 25'th Feb 2022 PR Newswire
NEW YORK, Feb. 25, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ: FENC). To receive updates on the lawsuit, fill out the form:…
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against New Oriental Education, Biogen, Telos, and Fennec and Encourages Investors to Contact the Firm
02:00am, Thursday, 24'th Feb 2022 GlobeNewswire
NEW YORK, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of New Oriental Education & Technology Group, Inc. (NYSE: EDU), Biogen, Inc. (NASDAQ: BIIB), Telos Corporation (NASDAQ: TLS), and Fennec Pharmaceuticals, Inc. (NASDAQ: FENC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
ROSEN, A LEADING NATIONAL FIRM, Encourages Fennec Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action FENC
12:30am, Wednesday, 23'rd Feb 2022 GlobeNewswire
NEW YORK, Feb. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the Class Period) of the important April 11, 2022 lead plaintiff deadline .
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - FENC
06:28pm, Friday, 18'th Feb 2022 PR Newswire
NEW YORK, Feb. 18, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the "Class Period") of the important April 11, 2022…
NEW YORK--(BUSINESS WIRE)---- $FENC--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Middle District of North Carolina on behalf of those who acquired Fennec Pharmaceuticals Inc. (“Fennec” or the “Company”) (NASDAQ: FENC) securities from May 28, 2021 to November 26, 2021 inclusive (the “Class Period”). Investors have until April 11, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Fennec is a b
FENC LAWSUIT ALERT: Levi & Korsinsky Notifies Fennec Pharmaceuticals Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
02:30pm, Thursday, 17'th Feb 2022 PR Newswire
NEW YORK, Feb. 17, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fennec Pharmaceuticals Inc. ("Fennec" or the "Company") (NASDAQ: FENC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fennec investors who were…
ROSEN, A TOP RANKED LAW FIRM, Encourages Fennec Pharmaceuticals Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – FENC
03:35pm, Wednesday, 16'th Feb 2022 GlobeNewswire
NEW YORK, Feb. 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) between May 28, 2021 and November 26, 2021, inclusive (the “Class Period”) of the important April 11, 2022 lead plaintiff deadline .
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fennec Pharmaceuticals Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of April 11, 2022 - (NASDAQ: FENC) | MarketScreener
02:31pm, Wednesday, 16'th Feb 2022 MarketScreener
NEW YORK, Feb. 16, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice on behalf of shareholders of Fennec Pharmaceuticals Inc.. Shareholders who purchased shares of FENC during… | February 16, 2022
FENC ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2022 in the Class Action Filed on Behalf of Fennec Pharmaceuticals Inc. Shareholders
02:30pm, Tuesday, 15'th Feb 2022 PR Newswire
NEW YORK, Feb. 15, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Fennec Pharmaceuticals Inc. (NASDAQ: FENC) alleging that the Company violated federal securities laws. Class Period: May 28, 2021 to November 26,…
